Danaher (DHR) CEO says there's modest recovery in pharmaceutical, especially in Europe; academic and research demand is fairly muted in USA and China, though generally stable

Danaher's CEO highlights a modest recovery in the pharmaceutical sector, particularly in Europe, which suggests potential opportunities for growth in that region.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Intercontinental Exchange (ICE) announced the launch of Reddit Signals and Sentiment that will give actionable news

German Economy expected to grow 1% in 2026 (prev. 1.3%) and cuts 2027 GDP growth forecast to 1.3% (prev. 1.4%)

Danaher (DHR) CEO says there's modest recovery in pharmaceutical, especially in Europe; academic and research demand is fairly muted in USA and China, though generally stable

Starbucks (SBUX) CFO continues to expect coffee prices and tariff pressures to peak in Q2 and find some relief in H2 '26 - conference call

Freeport LNG is reportedly considering rescheduling cargoes as heating demand spikes, according to Bloomberg reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

However, the muted demand in academic and research sectors in the USA and China raises concerns about broader market stability and may impact future performance projections for Danaher and its peers in the life sciences space.

Related headlines

The whole workspace, free to try.

Try it free